221 related articles for article (PubMed ID: 22528874)
1. Signification of Hypermethylated in Cancer 1 (HIC1) as Tumor Suppressor Gene in Tumor Progression.
Zheng J; Xiong D; Sun X; Wang J; Hao M; Ding T; Xiao G; Wang X; Mao Y; Fu Y; Shen K; Wang J
Cancer Microenviron; 2012 Dec; 5(3):285-93. PubMed ID: 22528874
[TBL] [Abstract][Full Text] [Related]
2. HIC1 (Hypermethylated in Cancer 1) epigenetic silencing in tumors.
Fleuriel C; Touka M; Boulay G; Guérardel C; Rood BR; Leprince D
Int J Biochem Cell Biol; 2009 Jan; 41(1):26-33. PubMed ID: 18723112
[TBL] [Abstract][Full Text] [Related]
3. [Chromosome arm 17p13.3: could HIC1 be the one ?].
Chopin V; Leprince D
Med Sci (Paris); 2006 Jan; 22(1):54-61. PubMed ID: 16386221
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of the hypermethylated in cancer 1 tumour suppressor--not just a question of promoter hypermethylation?
Jenal M; Britschgi C; Fey MF; Tschan MP
Swiss Med Wkly; 2010; 140():w13106. PubMed ID: 21104471
[TBL] [Abstract][Full Text] [Related]
5. Identification of the p53 family-responsive element in the promoter region of the tumor suppressor gene hypermethylated in cancer 1.
Britschgi C; Rizzi M; Grob TJ; Tschan MP; Hügli B; Reddy VA; Andres AC; Torbett BE; Tobler A; Fey MF
Oncogene; 2006 Mar; 25(14):2030-9. PubMed ID: 16301995
[TBL] [Abstract][Full Text] [Related]
6. The tumor suppressor Hic1 maintains chromosomal stability independent of Tp53.
Szczepny A; Carey K; McKenzie L; Jayasekara WSN; Rossello F; Gonzalez-Rajal A; McCaw AS; Popovski D; Wang D; Sadler AJ; Mahar A; Russell PA; Wright G; McCloy RA; Garama DJ; Gough DJ; Baylin SB; Burgess A; Cain JE; Watkins DN
Oncogene; 2018 Apr; 37(14):1939-1948. PubMed ID: 29367758
[TBL] [Abstract][Full Text] [Related]
7. Detailed mapping of chromosome 17p deletions reveals HIC1 as a novel tumor suppressor gene candidate telomeric to TP53 in diffuse large B-cell lymphoma.
Stöcklein H; Smardova J; Macak J; Katzenberger T; Höller S; Wessendorf S; Hutter G; Dreyling M; Haralambieva E; Mäder U; Müller-Hermelink HK; Rosenwald A; Ott G; Kalla J
Oncogene; 2008 Apr; 27(18):2613-25. PubMed ID: 17982487
[TBL] [Abstract][Full Text] [Related]
8. Scavenger chemokine (CXC motif) receptor 7 (CXCR7) is a direct target gene of HIC1 (hypermethylated in cancer 1).
Van Rechem C; Rood BR; Touka M; Pinte S; Jenal M; Guérardel C; Ramsey K; Monté D; Bégue A; Tschan MP; Stephan DA; Leprince D
J Biol Chem; 2009 Jul; 284(31):20927-35. PubMed ID: 19525223
[TBL] [Abstract][Full Text] [Related]
9. A L225A substitution in the human tumour suppressor HIC1 abolishes its interaction with the corepressor CtBP.
Stankovic-Valentin N; Verger A; Deltour-Balerdi S; Quinlan KG; Crossley M; Leprince D
FEBS J; 2006 Jul; 273(13):2879-90. PubMed ID: 16762039
[TBL] [Abstract][Full Text] [Related]
10. Cooperation between the Hic1 and Ptch1 tumor suppressors in medulloblastoma.
Briggs KJ; Corcoran-Schwartz IM; Zhang W; Harcke T; Devereux WL; Baylin SB; Eberhart CG; Watkins DN
Genes Dev; 2008 Mar; 22(6):770-85. PubMed ID: 18347096
[TBL] [Abstract][Full Text] [Related]
11. Identification and developmental expression of the zebrafish orthologue of the tumor suppressor gene HIC1.
Bertrand S; Pinte S; Stankovic-Valentin N; Deltour-Balerdi S; Guérardel C; Bégue A; Laudet V; Leprince D
Biochim Biophys Acta; 2004 Apr; 1678(1):57-66. PubMed ID: 15093138
[TBL] [Abstract][Full Text] [Related]
12. The tumor suppressor gene HIC1 (hypermethylated in cancer 1) is a sequence-specific transcriptional repressor: definition of its consensus binding sequence and analysis of its DNA binding and repressive properties.
Pinte S; Stankovic-Valentin N; Deltour S; Rood BR; Guérardel C; Leprince D
J Biol Chem; 2004 Sep; 279(37):38313-24. PubMed ID: 15231840
[TBL] [Abstract][Full Text] [Related]
13.
Dubuissez M; Paget S; Abdelfettah S; Spruyt N; Dehennaut V; Boulay G; Loison I; de Schutter C; Rood BR; Duterque-Coquillaud M; Leroy X; Leprince D
Oncotarget; 2020 Nov; 11(45):4138-4154. PubMed ID: 33227080
[No Abstract] [Full Text] [Related]
14. Hypermethylated in cancer 1 (HIC1) recruits polycomb repressive complex 2 (PRC2) to a subset of its target genes through interaction with human polycomb-like (hPCL) proteins.
Boulay G; Dubuissez M; Van Rechem C; Forget A; Helin K; Ayrault O; Leprince D
J Biol Chem; 2012 Mar; 287(13):10509-10524. PubMed ID: 22315224
[TBL] [Abstract][Full Text] [Related]
15. An acetylation/deacetylation-SUMOylation switch through a phylogenetically conserved psiKXEP motif in the tumor suppressor HIC1 regulates transcriptional repression activity.
Stankovic-Valentin N; Deltour S; Seeler J; Pinte S; Vergoten G; Guérardel C; Dejean A; Leprince D
Mol Cell Biol; 2007 Apr; 27(7):2661-75. PubMed ID: 17283066
[TBL] [Abstract][Full Text] [Related]
16. The Reelin receptors ApoER2 and VLDLR are direct target genes of HIC1 (Hypermethylated In Cancer 1).
Dubuissez M; Faiderbe P; Pinte S; Dehennaut V; Rood BR; Leprince D
Biochem Biophys Res Commun; 2013 Oct; 440(3):424-30. PubMed ID: 24076391
[TBL] [Abstract][Full Text] [Related]
17. The receptor tyrosine kinase EphA2 is a direct target gene of hypermethylated in cancer 1 (HIC1).
Foveau B; Boulay G; Pinte S; Van Rechem C; Rood BR; Leprince D
J Biol Chem; 2012 Feb; 287(8):5366-78. PubMed ID: 22184117
[TBL] [Abstract][Full Text] [Related]
18. HIC1 Tumor Suppressor Loss Potentiates TLR2/NF-κB Signaling and Promotes Tissue Damage-Associated Tumorigenesis.
Janeckova L; Pospichalova V; Fafilek B; Vojtechova M; Tureckova J; Dobes J; Dubuissez M; Leprince D; Baloghova N; Horazna M; Hlavata A; Stancikova J; Sloncova E; Galuskova K; Strnad H; Korinek V
Mol Cancer Res; 2015 Jul; 13(7):1139-48. PubMed ID: 25934696
[TBL] [Abstract][Full Text] [Related]
19. Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses.
Chen WY; Wang DH; Yen RC; Luo J; Gu W; Baylin SB
Cell; 2005 Nov; 123(3):437-48. PubMed ID: 16269335
[TBL] [Abstract][Full Text] [Related]
20. Genomic deletion and promoter methylation status of Hypermethylated in Cancer 1 (HIC1) in mantle cell lymphoma.
Stöcklein H; Hutter G; Kalla J; Hartmann E; Zimmermann Y; Katzenberger T; Adam P; Leich E; Höller S; Müller-Hermelink HK; Rosenwald A; Ott G; Dreyling M
J Hematop; 2008 Sep; 1(2):85-95. PubMed ID: 19669207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
